News

News


20 May 2010
Dr Klaus M Leisinger, President and Managing Director of the Novartis Foundation for Sustainable Development, and Dr Hiro Nakatani, WHO Assistant Director-General Dr Klaus M Leisinger, President and Managing Director of the Novartis Foundation for Sustainable Development , and Dr Hiro Nakatani, WHO...
20 May 2010
Global Health Council On May 20, the Center hosted a briefing with leading scientists and advocates on combating the dual epidemics of HIV and TB: Changing Course: Stemming the Deadly Twin Epidemics of HIV and Tuberculosis . A complete wrap-up of the event can be found at this online press room ...
19 May 2010
Professor of Microbiology and Immunology and of Molecular Genetics, Albert Einstein College of Medicine. This video was recorded on November 13, 2009 at Johns Hopkins University. Dr. Bill Jacobs Jacobs moved to Albert Einstein College of Medicine in 1985 to become a postdoc with Barry Bloom, who...
18 May 2010
Global tuberculosis drug development pipeline: the need and the reality by Zhenkun Ma, Christian Lienhardt, Helen McIlleron, Andrew J Nunn, Xiexiu Wang Today, The Lancet published a series of articles on tuberculosis, which highlights the continued devastating global impact of this disease, the...
17 May 2010
Left unchecked, TB could claim up to 90% of lions in a national park Tuberculosis is currently a leading infectious disease in both human and animal populations across the world. Because it is an older disease, it goes under recognized in all groups – especially wildlife. While it may not generate...
17 May 2010
This post originally appeared on SciDev.net The patent pool may boost research into neglected diseases, such as guinea worm infection. CDC PHIL (8224) by Linda Nordling 10 May 2010 [CAPE TOWN] An industry-led ‘patent pool’, set up last year to target neglected diseases, has finally yielded some...
12 May 2010
Dr. Gyanu Lamichhane is Assistant Professor, Division of Infectious Diseases at the Johns Hopkins University Center for Tuberculosis Research Labs. This interview was conducted at JHU on November 13, 2009. The following bio is excerpted from this bio sketch (.pdf – 80kb) , which includes a list of...
12 May 2010
Grand Challenges Canada's Chief Executive Officer (CEO) Dr. Peter A. Singer looks on as Canada's Finance Minister Jim Flaherty (R) holds a microscope Dear Colleagues, It is a great pleasure to announce the launch of Grand Challenges Canada / Grands Défis Canada – an innovative organization that...
10 May 2010
Dr. Michele Miller, Chief Veterinary Officer and Director of the Center for Conservation Medicine at the Palm Beach Zoo When we think of infectious diseases, such as HIV or Tuberculosis , we usually consider them to be a human problem – there are rarely reports of disease in animals, unless it...
9 May 2010
TBVI The University of Zaragoza (Spain), together with TuBerculosis Vaccine Initiative (TBVI) and the Spanish Fundación Ramón Areces, presents an international symposium: “Research and Development of new Tuberculosis Vaccines”. This symposium will be held on 3 and 4 June in Zaragoza, Spain. During...
5 May 2010
Dr. Joel S. Freundlich Dr. Joel S. Freundlich attended Cornell University as a McMullen scholar and an Exxon scholar, attaining his B.S. degree with Distinction in Chemical Engineering in 1991 and his M. Eng. degree in Chemical Engineering in 1992. He received his Ph.D. degree in 1996 in Organic...
4 May 2010
Stop TB Partnership The Stop TB Partnership’s TB REACH initiative today announced the recipients of its first wave of grants to organizations that will engage in innovative approaches to increasing detection of tuberculosis (TB). Thirty applicants from 19 countries will together receive US$ 18.4...
3 May 2010
isoniazid structure Over the last month, a few reports about new positive TB cases have surfaced from FL, involving students at a couple of high schools and at a college. Information was not made available as to how the original infected TB individuals contracted TB. Furthermore, it is not clear...
2 May 2010
New research to speed TB drugs to those who need it most New York and Bangalore, India, May 3, 2010 The TB Alliance and AstraZeneca announced today at the 2010 BIO International Convention that they have entered into a research collaboration agreement to accelerate the discovery, development and...
29 Apr 2010
We first read this post at FierceBiotech.com . New drugs are needed to combat MDR-TB HAYWARD, Calif. and SHANGHAI, April 6 /PRNewswire/ — MicuRx Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the development of antibiotics to treat drug-resistant bacteria, and Cumencor...

Pages